Anagenics Limited · ASX:AN1
Anagenics — FY2025 Earnings Presentation
15 slides from Anagenics's earnings presentation, Aug 28, 2025
Slide 1: FY25 Result
28 August 2025 FY25 Result Anagenics Limited (ASX: AN1)
Slide 2: Portfolio of innovative health, beauty, and wellness brands
Anagenics is developing a portfolio of innovative health, beauty, and wellness brands and solutions PRIORI /skin uSDa. regimen/Lx MANDA
Slide 3: Income Statement
Income Statement A$’000 FY24 FY25 Following the recent restructure: Revenue 10,803 5,119 - Gross Proft margin has improved Cost of Sales (6,442) (2,709) - Operating Expenses have been recalibrated; Gross Profit 4,361 2,410 - Revenue & Other Income has been largely Gross Profit margin 40.4% 47.1% ret
Slide 4: Total Operating Expenses / Revenue & Other Income
Total Operating Expenses / Revenue & Other Income Operating Expenses (monthly average) 109.6% $721k 73.2% $283k FY24 FY25 FY24 FY25 Note: Includes Business Restructure Expense Note: Excludes Business Restructure Expense A u gu s t 2 0 2 5
Slide 5: Balance Sheet
Balance Sheet A$’000 FY24 FY25 Cash and cash equivalents 1,624 396 Trade and other receivables 652 575 Inventories 1,476 968 Other assets 76 - Plant and equipment 51 17 Right of use assets 360 194 Intangibles 1,952 1,952 Total Assets 6,191 4,102 Trade and other payables 2,071 1,399 Loans and borrowi
Slide 6: Operating Cash Flow ($k)
Operating Cash Flow ($k) 1Q25 2Q25 3Q25 4Q25 Operating Cash Flows have improved materially as a result of the restructure. 132 (356) (424) (928) A u gu s t 2 0 2 5
Slide 7: Change picture
Change picture During FY25, Anagenics has: - Rationalised the brand portfolio, which has improved profitability and working capital management - Significantly improved operating cash flow, reversing a 1Q25 operating cash outflow of $928k to an operating cash inflow of $132k in 4Q25. - Signed a multi
Slide 8: Management and board focus following restructure
With the business restructure now largely complete, the management and board of Anagenics are focused on: Maintaining recent profitability - Based on recent cost improvements and royalty wins Reinforcing royalty revenue streams - Targeting new agreements per the recent York Street Brands deal New br
Slide 9: Key Brands
Slide 10: Key brand descriptions
French Marine Skincare founded in 1964, Italian vegan & highly concentrated natural Pioneer in biotech-based skincare innovation; specialising in products made with algae and skincare with over 25 years in the spa and looks at skin’s biological structure & metabolism marine extracts wellness sector
Slide 11: Products formulated for daily rituals that promote strong, vibrant hair
Products are formulated for daily rituals that promote strong, vibrant Anti-ageing hair care collection focused on harnessing the latest hair, especially for those with long hair or those aspiring to grow it scientific research to give thicker, stronger, healthier hair. Their longer. Each product is
Slide 12: 7
7
Slide 13: Key Strategic Growth Pillar / Exclusive House of Brands
Commitment to “Exclusive House of Brands” Strategy 2025 launch of premium Norwegian haircare brand Manda. Ongoing commitment to health and wellness Key Strategic Growth industry, aligned brand partnerships and Pillar product innovation and expanded offering for Includes USPA & Evolis IP, clients and
Slide 14: Delivering our Brands to the Consumer
Delivering our Brands to the Consumer 380 loyal and passionate salon and spa partners, 7 professional ‘E-tailers’ and BLC owned websites to support our exclusive brands and strengthen unique brand Long Term Royalty Income Stream positioning in the professional market. 2024 consolidated strong strate
Slide 15: Sandy Beard, Chair Anagenics Ltd.
Sandy Beard Chair Anagenics Ltd. Ph: 0412 308 263 E: sandy@xvgroup.com.au